Brucella spp. are facultative intracellular pathogens that have the ability to survive and multiply in professional and non-professional phagocytes, and cause abortion in domestic animals and undulant fever in humans. The mechanism and factors of virulence are not fully understood. Nicotinamidase/pyrazinamidase mutant (pncA mutant) of Brucella abortus failed to replicate in HeLa cells, and showed a lower rate of intracellular replication than that of wild-type strain in macrophages. Addition of nicotinic acid, but not nicotinamide, into medium supported intracellular replication of pncA mutant in HeLa cells and macrophages. The pncA mutant was not co-localizing with either late endosomes or lysosomes. The B. abortus virB4 mutant was completely cleared from the spleens of mice after 4 weeks, while the pncA mutant showed a 1.5-log reduction of the number of bacteria isolated from spleens after 10 weeks. Although pncA mutant showed reduced virulence in mice and defective intracellular replication, its ability to confer protection against the virulent B. abortus strain 544 was fully retained. These results suggest that PncA does not contribute to intracellular trafficking of B. abortus, but contributes to utilization of nutrients required for intracellular growth. Our results indicate that detailed characterizations of the pncA mutant may help the improvement of currently available live vaccines.
Introduction
Brucellosis is a major bacterial zoonosis that causes a serious debilitating disease in humans and abortion and sterility in domestic animals. The etiologic agents of brucellosis are Brucella spp., small gram-negative and facultative intracellular pathogens that can multiply within professional and non-professional phagocytes [1, 2] . In contrast to other intracellular pathogens, Brucella species do not produce exotoxins, antiphagocytic capsules or thick cell walls, resistant forms or fimbriae and do not show antigenic variation [3] . A key aspect of the virulence of Brucella is its ability to proliferate within professional and non-professional phagocytic host cells, thereby successfully bypasses the bactericidal effects of phagocytes, and their virulence and chronic infections are thought to be due to their ability to avoid the killing mechanisms within host cells [4, 5] . The molecular mechanisms and genetic basis for intracellular survival and replication, however, are not understood completely. Some studies with non-professional phagocytes have shown that Brucella invades host cells and is contained within early endosome-like vacuoles. These vacuoles rapidly fuse with early autophagosomes that acquire vacuolar H þ -ATPase and lysosome-associated membrane proteins (LAMP), mature into a late auto-phagosome, inhibit fusion with lysosome and finally become a replicating vacuole normally associated with the endoplasmic reticulum [4, [6] [7] [8] . The genetic basis of Brucella virulence is still poorly understood. The VirB type IV secretion system of Brucella has been identified recently [9] . This operon is composed of 13 open reading frames (ORFs) that share homology with other bacterial type IV secretion systems in the intracellular trafficking of pathogens. Bacteria with deletion or polar and nonpolar mutations of these ORFs were not able to replicate and survive within phagocytes [10, 11] . Thus, the VirB proteins of B. abortus are thought to be constituents of the secretion apparatus.
A preliminary characterization of Brucella abortus pncA (nicotinamidase) mutant showed that it had reduced intracellular growth within HeLa cells [12] , suggesting that this nicotinamidase might be a virulence-associated factor. In this study, we examined the virulence of B. abortus pncA mutant in mice and their intracellular replication in macrophages. The protection induced in mice by a B. abortus pncA mutant against a challenge with the virulent strain B. abortus 544 was also evaluated.
Materials and methods

Bacterial strains and media
All bacterial strains employed in this study are the derivatives from B. abortus 544 (ATCC23448), a smooth virulent B. abortus biovar 1 strain. Isogenic mutants of B. abortus 544 pncA::Tn 5Km2 and DvirB4 were described previously [11, 12] . All these strains were maintained as frozen glycerol stocks and were cultured in Brucella broth (Becton Dickinson, Sparks, MD) or Brucella broth containing 1.5% agar. Kanamycin (30 lg/ml) and ampicillin (100 lg/ml) were used when necessary.
pSK pncA (pncA þ ) was constructed by cloning a PCR fragment into KpnI/SacI-cleaved pBBR1MCS-4 [13] . The 1195-bp KpnI-SacI PCR fragment spanned a site located 393 nucleotides upstream of the 5' end of pncA to a position 48 nucleotides downstream from the 3 0 -end [14] and was amplified using the primers 5 0 -GGTACCGCATC-TGCGGCACCTGCAAGG-3 0 (KpnI site underlined) and 5 0 -GAGCTCAACCCGAACTGGCAGAACGAG-3 0 (SacI site underlined).
Cell culture
HeLa cells were grown at 37°C in a 5% CO 2 atmosphere in eagle minimum essential medium (MEM) (Sigma, St. Louis, MO) containing 10% fetal bovine serum (FBS). Bone marrow-derived macrophages from female BALB/c mice were prepared by the method described previously [15] . After culture in L-cell conditioned medium, macrophages were harvested and resuspended in RPMI 1640 (Sigma) containing 10% FBS. The HeLa cells or macrophages were seeded (2-3 Â 10 5 per well) in 24-well tissue culture plates one day before infection for all assays.
Comparative growth of the mutants in minimal medium
Growth of the pncA mutant in minimal media, RPMI 1640, which contains no nicotinic acid and 1 lg/ml nicotinamide, was assessed according to the modified method described previously [16, 17] . Briefly, 2-3 Â 10 10 colony forming units (CFU) of B. abortus wild-type, pncA mutant and complemented strain were pelleted at 8000 rpm for 15 min and resuspended to 2-3 Â 10 7 CFU/ml in RPMI 1640 with 0.3 mM nicotinic acid or 0.3 mM nicotinamide, and then were incubated at 37°C for 0, 6, 24 and 48 h with shaking. To measure the CFU of brucellae, equal portions were withdrawn from each culture, serially diluted into PBS, and spread on the surface of brucella plates to determine the number of viable cells at intervals of up to 48 h.
Intracellular growth of the mutants in cultured HeLa cells and macrophages
Bacterial infection and intracellular survival assay were done by using the modified method described previously [12] . Briefly, HeLa cells or mouse bone marrow-derived macrophages were grown on 24-well microtiter plates in MEM or RPMI 1640 with 10% FBS. Cells were infected with B. abortus strains at a multiplicity of infection (MOI) of 20 by centrifugation at 150g for 10 min at room temperature. To determine the effect of disruption of nicotinamidase in vivo, HeLa cells or macrophages were preincubated for 30 min with the nicotinic acid (0.1 mM) and nicotinamide (0.1 mM) [16] , and infected with bacteria as above.
After centrifugation, infected cells were incubated at 37°C in a 5% CO 2 for 30 min, washed twice with 0.5 ml of sterile PBS and cultured in the media containing gentamicin (30 lg/ml) in the presence or absence of 0.1 mM nicotinic acid or nicotinamide for 2, 24 and 48 h. Serial dilutions of the infected cells lysed with distilled water were plated onto Brucella plates for determination of CFU.
LAMP-1 staining
LAMP-1 staining was performed as described previously [15] . Briefly, infected macrophages were fixed in 4% periodate-lysine-paraformaldehyde (PLP)-sucrose for 1 h at 37°C. All antibody-probing steps were for 1 h at 37°C
. Samples were washed three times in PBS for 5 min and then were permeabilized at )20°C in methanol for 10 s. After incubating three times for 5 min with a blocking buffer (2% goat serum in PBS), the samples were stained with anti-LAMP-1 rat monoclonal antibody 1D4B, which was obtained from the Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine and the Department of Biology, University of Iowa, diluted 1:100 in blocking buffer. After washing three times for 5 min in blocking buffer, the samples were stained with Texas red-goat anti-rat IgG (Molecular Probes, Inc.). Then the samples were stained with anti-B. abortus polyclonal rabbit serum [11] and fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (Molecular Probes, Inc.) in blocking buffer to identify the bacteria, and then they were placed in mounting medium and were visualized by fluorescence microscopy. One hundred bacteria within macrophages were selected randomly and the LAMP-1-positive bacteria were counted.
Virulence determination in mice
Six-week-old female BALB/c mice were infected intraperitoneally with approximately 10 4 CFU of brucellae in 0.1 ml saline. Groups of five mice were infected with each strain. At each week post-infection, mice were sacrificed by decapitation and their spleens were removed, weighed and homogenized in saline. Tissue homogenates were serially diluted with PBS and were plated on Brucella agar to count the number of CFU in each spleen to assess the virulence of each strain.
Vaccination against challenge infection with a virulent strain
Six-week-old BALB/c mice were vaccinated with 10 4 CFU of B. abortus S19 or pncA mutant. Each group consisted of five mice. At 8 weeks postvaccination, mice were challenged intraperitoneally with approximately 10 4 CFU of a virulent strain, B. abortus 544. Two weeks after the challenge, the numbers of viable B. abortus 544 in the spleens and the weights of the spleens were determined as described [11] .
Results
Effect of disruption of pncA in vitro and in vivo
Brucella wild-type and complemented strain showed almost the same growth yield but pncA mutant showed a different growth comparing to that of wild-type in RPMI 1640, RPMI 1640 with nicotinic acid or nicotinamide (Fig. 1A, B and C) . In the media with nicotinamide, two strains with intact pncA showed almost the same growth yield but pncA mutant did not grow (Fig. 1A and C) . In the media with nicotinic acid, growth of pncA mutant was restored (Fig. 1B) .
As survival and multiplication in professional and non-professional phagocytic host cells is an important virulence mechanism of Brucella, we examined the intracellular replication of Brucella strains in HeLa cells and mouse bone marrow-derived macrophages. The pncA mutant failed to replicate in HeLa cells, and displayed a lower rate of intracellular replication in Fig. 1 . Bacterial growth of wild-type and pncA mutants under minimal medium condition. Wild-type B. abortus, pncA mutant (pncA)) and complemented strain (pncA+) were grown in RPMI 1640 (A), RPMI 1640 with nicotinic acid (B) or nicotinamide (C) as described in Section 2. The numbers of viable bacteria at each time point were determined by making serial dilutions in PBS and plating on Brucella plates. Data points and error bars represent the mean CFU of triplicate samples from a typical experiment (performed at least four times) and their standard deviation.
macrophages than the wild-type strain and complemented strain ( Fig. 2A and B) . To further analyze the effect of disruption of nicotinamidase, cells were preincubated in the media supplemented with nicotinic acid or nicotinamide and then infected with Brucella strains. In the presence of nicotinic acid, pncA mutant was able to replicate inside the cells as well as wild-type (Fig. 2C and   D ). In the medium with nicotinamide, the pncA mutant, which was unable to convert nicotinamide to nicotinic acid, showed a reduced ratio of intracellular replication in HeLa cells and macrophages as compared to that in other two strains ( Fig. 2E and F) . Nicotinamide deamidase is known to be released into medium from HeLa cells and macrophages and converts nicotinamide into nicotinic acid for NAD synthesis [18, 19] . Therefore, it is likely that by internalizing little amounts of nicotinic acid, pncA mutant was able to replicate to some extent in medium with nicotinamide.
Phagosomes containing virulent B. abortus are reluctant to fuse with lysosomes, whereas dead B. abortus phagosomes co-localize with endocytic compartments in the early stage of infection in macrophages [20] . To test the ability of B. abortus to target properly within macrophages early in infection, interaction of the mutants with the endocytic pathway was quantified by immunofluorescence localization of LAMP-1, a membrane protein of late endosomes and lysosomes [21] . As expected, most phagosomes containing the wild-type and complemented strain did not co-localize with the LAMP-1 (15.2 AE 2.3% or 13.8 AE 4.2% positive). Interestingly, pncA mutation did not affect LAMP-1 acquisition (17.2 AE 4.8% positive) (Fig. 3) . It suggests that both wild-type strain and pncA mutant are not co-localizing with either late endosomes or lysosomes.
B. abortus pncA mutant has reduced virulence in mice
To assess whether the reduced in vitro virulence of pncA mutant as determined by the replication within HeLa cells and macrophags correlates with a virulence in the host, mice were infected with wild-type B. abortus, pncA and virB4 mutant. As bacterial growth in spleen and liver are same level [22, 23] , only bacterial growth in spleen was checked in this study. Two weeks after infection, many bacteria were recovered from the spleen of mice infected with the wild-type strain (6.7 Â 10 5 CFU/spleen), but fewer bacteria were recovered from mice infected with pncA mutant (4.2 Â 10 4 CFU/spleen) (Fig. 4A ). Bacteria were still recovered from the spleen of mice infected with wild-type strain at 10 weeks after infection (6.8 Â 10 3 CFU/spleen), while fewer bacteria were recovered from mice infected with pncA mutant (7.8 Â 10 2 CFU/spleen). In contrast, virB4 mutant was cleared to the undetectable level in the spleen at four weeks after infection (Fig. 4A) .
Wild-type strain induced splenomegaly as a consequence of host inflammatory response, but pncA mutant induced a reduced response compared to that of the wild-type strain (Fig. 4B) . Splenomegaly was not observed at all in mice infected with virB4 mutant.
Effect of vaccination with B. abortus pncA mutant
One of the drawbacks of the vaccine strain B. abortus S19 is that it displays some degree of virulence causing abortion in pregnant cows [24] . In order to determine if the less pathogenic pncA mutant remains immunogenic, Fig. 3 . Localization of pncA mutant and late endosomal and lysosomal marker LAMP-1 in bone marrow-derived macrophages by immunofluorescence microscopy. Macrophages were infected with wild-type or pncA mutant for 1 h, fixed and stained for LAMP-1 and intracellular bacteria. 4 CFU of pncA mutant or strain S19. Eight weeks postvaccination, mice were challenged with B. abortus 544. Two weeks later, mice were killed and the numbers of viable Brucella recovered from the spleens (A) and the weights of the spleens (B) were determined as described in Section 2. Error bars indicate standard deviation. experiment of protection was carried out in mice. It was shown that vaccination with B. abortus pncA mutant protected mice against a challenge with the virulent strain B. abortus 544 to the same extent as B. abortus S19 (Fig. 5) . This indicated that pncA mutant with a reduced virulence and an impaired ability for intracellular multiplication completely retained the ability to induce the protective immunity in mice.
Discussion
The pncA gene encoding nicotinamidase/pyrazinamidase is an enzyme involved in the production of NAD. Salmonella emterica serovar Typhimurium and Escherichia coli use PncA in the preferred exogenous pathway for NAD synthesis [25] . In the less preferred endogenous pathway, NadB, NadA, NadC catalyse the conversion of aspartate to nicotinate D D -ribonucleotide. The genome of Brucella melitensis and Brucella suis contains PncA and PncB, NadD and NadE, but not NadB, NadA or NadC [14] . Likewise, B. abortus may rely upon a single pathway for NAD synthesis. B. abortus lacking pncA was able to survive and grow in vitro because Brucella broth contains nicotinamide, nicotinic acid, NAD and NADP. One or more of these compounds may permit the growth of pncA mutant at the same rate as wild-type strain. It is also possible that PncA participates in other pathways required for survival and growth in vivo. As a recent study reported that plasmid-encoded PncA contributed to infectivity of Borrelia burgdorferi in mice [16] , PncA may have important roles for virulence of intracellular pathogens. Our results in this study indicate that both wild-type strain and pncA mutant prevent phagosome-lysosome fusion after uptake by macrophages. Thus, PncA does not contribute to intracellular trafficking of B. abortus, but contribute to utilization of nutrients required for intracellular growth.
PncA is involved in the conversion of pyrazinamide to pyrazinoic acid. Pyrazinamide is an important antituberculosis drug and mutation of pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis [26] . Unlike most antibacterial agents, pyrazinamide, despite its remarkable in vivo activity, has no activity against M. tuberculosis in in vitro except at an acidic pH [27] . Presumably, pyrazinamidase would act under acidic environment. Vacuole acidification in phagocytic cells to pHs between 4.0 and 4.5 has been shown to be essential for intracellular survival during early infection by B. suis [28] . Pyrazinamidase may participate in the resistance of Brucella spp. to the acidic condition of the phagosome.
B. abortus virB mutant was cleared from the infected mice faster than wild-type strain. On the other hand, pncA mutant did not replicate in mouse spleen, but it was not cleared from the infected mice soon. These results indicate that virB genes have important roles in resistance to clearance by host immunity. Our results showed that the pncA mutant protected mice against a challenge with the pathogenic B. abortus strain 544 to the same extent as attained by the B. abortus vaccine strain S19. The decreased virulence with retention of the capacity to confer immunity suggests that detailed characterizations of the pncA mutant may improve current live vaccines.
